Organon Acquired by Sun Pharma | Healthcare M&A Deal

Sun Pharma has acquired Organon, a pharmacy business in the US, for $11.75 billion enterprise value. Sun Pharma acquisitions aim to expand global branded and women’s health portfolios, while Organon is a healthcare company with a large international footprint across about 140 countries. Organon acquisition economics include FY25 revenues of about $6.2 billion, with roughly 28% from Women’s Health and a product base of more than 70 therapies. The strategic acquisition is structured as a merger acquisition announced for early 2027 subject to regulatory approvals and Organon shareholder consent, funded via available cash and committed bank financing.